In this conversation, Dr. Olivia Lee and Dr. John Irvine discuss the collaboration between Doheny Eye Institute and City of Hope, consulting on graft-vs-host disease (GVHD) in patients suffering from symptoms that affect their eyesight.
A conversation with Dr. Micheal Ip, Director of the Doheny Image Reading Center, and Dr. Gemmy Cheung, head of the Retina Research Group at the Singapore Eye Research Institute.
A conversation with Dr. Alex Huang, Doheny-UCLA research-scientist, and Dr. Naama Hammel, Clinical Research Scientist at Google Artificial Intelligence Healthcare.
A conversation with Dr. Benjamin Bert, and Doheny-UCLA clinical fellow, Dr. Arpine Barsegian about corneal collagen cross-linking, a breakthrough procedure for patients with thinning corneas.
Artificial Intelligence (AI) at Doheny: Learn about AI as an emerging and exciting tool to aid in diagnosing ocular disease as well as its capabilities to link disease prevention, treatment and patient outcomes.
A conversation about clinical trials with Dr. Alfredo Sadun. Patients in treatment often ask about participation in these drug tests. Dr. Sadun explains how doctors and researchers decide who makes a good candidate for a clinical trial, how to ensure a trial is legitimate, and the impact of clinical trial research on his own work throughout his career in neuro-ophthalmology.